1 / 20

By: Suha Saleh Supervisor: Prof. Sharon Lewin Monash University,Melbourne, Australia

Latent HIV infection can be established in resting CD4+ T-cells in vitro following incubation with multiple diverse chemokines. By: Suha Saleh Supervisor: Prof. Sharon Lewin Monash University,Melbourne, Australia. INTRODUCTION. HIV latency represents a major barrier to HIV eradication.

norman-kemp
Download Presentation

By: Suha Saleh Supervisor: Prof. Sharon Lewin Monash University,Melbourne, Australia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Latent HIV infection can be established in resting CD4+ T-cells in vitro following incubation with multiple diverse chemokines By: Suha Saleh Supervisor: Prof. Sharon Lewin Monash University,Melbourne, Australia

  2. INTRODUCTION • HIV latency represents a major barrier to HIV eradication. • HAART successfully suppresses HIV replication but cannot eradicate HIV. • The major stable source of this latent reservoir is resting memory CD4+ T-cells which decays very slowly. - Chun et al., Nat. Med., 1995; Chun et al., Nature, 1997; Finzi et al., Science, 1997. • Infected naïve CD4+ T-cells also represent a long lived reservoir. - Brenchley et al., J Virol., 2004.

  3. Pre-integration Resting CD4+ T cell Blood OR Post-integration Lymphoid organs Kreisberg et al., J Exp Med 2006; 203:865; Eckstein et al, Immunity 2001; 15: 671; Audige et al, J Immunol 2004; 172: 2687 Infection of activated and resting T cells Activated CD4+ T cell

  4. High frequency of integrated HIV-1 in resting cells incubated with CCR7 ligand (CCL19) Saleh et al., Blood 2007; 110:4161

  5. NL4-3 infection [n=6] Unstimulated IL2/PHA CCL19 mock AD8 infection [n=3] Low level productive infection with CCL19 consistent with latent infection 1000 RT CPM/ul 100 1000 RT CPM/ul 100 0 2 3 6 4 5 7 1 Days after infection Saleh et al., Blood 2007; 110:4161

  6. Chemokine receptors and T-cells

  7. HYPOTHESIS: CCR7 ligation by CCL19 activates a pathway common to multiple chemokine receptors leading to the establishment of latent HIV-1 infection of resting CD4+ T-cells. AIMS: • To determine whether other chemokines that bind receptors expressed on resting CD4+ T-cells can mediate HIV-1 latency. • To determine the effect of CCL19 treatment on pre-integration steps in the virus life cycle.

  8. Gene expression of chemokine receptors on resting CD4 T cells with and without CCL19 Tested ligands CCL20 CXCL9, CXCL10 CCL13 CCL1

  9. Methods:

  10. Multiple CXC and CC chemokines facilitate HIV proviral DNA integration in resting T cells A B

  11. No change in the expression of chemokine receptors or activation markersfollowing incubation with different chemokines

  12. R U5 gag pol env U3 R PBS Aim 2:Characterise steps pre viral integration in CCL19 treated resting CD4+ T-cells Primer pairs for DNA Viral DNAform R/U5 R/gag 2-LTR Alu-HIV Cytoplasm M667 AA55 + - - - + + - - + + + - + + - + (HIV-1 genomic RNA) Strong-stop M667 M661 Full-length U3 R U5 gag pol env U3 R U5 Nucleus 2-LTR circles Integrated Zack et al., Cell 1990; 61:213, Butler et al., Nat.Med. 2001; 7:631., O’Doherty et al., J Virol. 2002;76:10942

  13. Enhanced nuclear localisation in CCL19-treated cells Primer pairs for DNA Viral DNAform R/U5 R/gag 2-LTR Alu-HIV + - - - Strong-stop + + - - Full-length + + + - 2-LTR circles + + - + Integrated

  14. Delayed appearance of 2-LTR circles and low level integration in unactivated cells

  15. NFkB Chemokine receptor signalling: shared pathways CCR7, CXCR3, CCR6 Survival Chemotaxis Migration NF-kB JNK Cofilin Sanchez-Sanchnez et al ., J. Immunol. 2006; 176:5153 HIV envelope-CXCR4 signalling activates cofilin to overcome cortical action restriction in resting CD4 T cells Yoder et al, Cell 2008; 134: 782

  16. Chemokines, cofilin activation and infection of resting T-cells • HIV-induced signaling from CXCR4 activates phosphatase which dephosphorylates and activates cofilin. • This leads to depolymerization of F-actin, releasing HIV-1 reverse transcription complexes and promotes its translocation towards the nucleus. Yoder et al, Cell 2008; 134: 782

  17. 10nM PMA 100nM CCL19 pCofilin/ Cofilin Ratio Cofilin pCofilin/ Cofilin Ratio 1 0.5 merge 0 0 2 5 10 15 30 0 2 5 10 15 30 0 10 20 30 0 10 20 Time minutes Time minutes Chemokine induced changes cofilin pCofilin 30 CCL19 CCL19 CCL19 CCL19 100nM CCL19 100nM CCL19 100nM 0 min 0 min 0 min SDF-1 100nM SDF-1 100nM SDF-1 100nM 5 min 5 min 5 min Control Control Control 15 min 15 min 15 min 200 200 200 30 min 30 min 30 min LAT-A LAT-A LAT-A 150 150 150 SDF-1 SDF-1 SDF-1 100 100 100 0 min 0 min 0 min 5 min 5 min 5 min 30 min 30 min 30 min 50 50 50 LAT-A 5 min LAT-A 5 min LAT-A 5 min 0 0 0 20 20 20 30 30 30 1 1 1 10 10 10 2 2 2 3 3 3 4 4 4 0 0 0 Log FITC Phylloidin Log FITC Phylloidin Log FITC Phylloidin

  18. MFI phylloidin fluorescence CCL19 100nM SDF-1 100nM LAT-A Cytokine induced changes in F-actin CCL19 0 min 5 min 15 min 200 30 min 150 SDF-1 100 MFI phalloidin fluorescence 0 min 5 min 30 min 50 LAT-A 5 min 0 20 30 1 10 2 3 4 0 Log FITC Phalloidin Time min

  19. Summary: • Stimulation of resting memory CD4+ T cells with multiple chemokines leads to a high level of HIV-1 integration and low level of productive HIV-1 infection in the absence of cell activation. • Enhanced integration in chemokine treated resting cells was secondary to increased nuclear localisation and efficient integration. • CCL19 leads to significant activation of cofilin and modest changes in actin polymerisation that may facilitate HIV entry into the nucleus of resting CD4 T-cells. • A novel in vitro model of latent HIV infection.

  20. Acknowledgements • Department of Medicine, Monash University • Prof. Sharon Lewin • Dr. Paul Cameron • Georgina Sallman • Ajantha Solomon • Fiona Wightman • Vanessa Evans • Burnet Institute • Johnson Mak • Kate Jones • Jenny Anderson • Anthony Jaworwski • Westmead Millenium Research Institute • Tony Cunningham • Andrew Harman American Foundation for AIDS Research National Health and Medical Research Council of Australia

More Related